Proventec plc (AIM:PROV, Alternext:ALPTC), a provider of specialist cleaning and coatings technologies, is pleased to announce it has received an initial £450,000 order from the Scottish NHS for its specialist steam cleaning machines.
Commenting on the importance of addressing infections in Scottish hospitals, the Scottish Health Secretary, Nicola Sturgeon, said: "Tackling healthcare-associated infections is my top priority because it is vital that the public have confidence in the care they will receive if they need hospital treatment. Steam cleaning is a particularly effective way of cleaning areas affected by Clostridium difficile and substantially increasing the number of steam cleaners available to the NHS will ensure they are available locally when needed."
This is Proventec's first order from the Scottish NHS and was received shortly after the Company recently won the HCAI ("Healthcare Acquired Infections Innovations") award from the Department of Health for its contribution to enhancing the cleanliness of the hospital environment.
In addition, the Company is also pleased to announce it recently won a £99,200 competitive Research & Development contract from the NHS National Institute for Health Research, through a Healthcare Associated Infections competition. This contract, part of the UK Small Business Research Initiative ("SBRI") program, is to develop a novel hand hygiene technology. The Company will receive the funds on completion of the first phase of development and assessment of its design in September 2009. The Company has already started development and it is expected that it will take six months to complete the technology and conduct the first phase of performance trials and user evaluation studies. The R&D evaluation is being conducted in association with Campden Chorleywood Food Research Agency and the Royal College of Nurses.
David Chestnutt, Chief Executive of Proventec, said: "We are delighted to be working with the Scottish NHS, which has recognised the value of our technology in combating healthcare acquired infections. Following successful implementation of this initial order, we hope to receive further orders from the NHS in Scotland."
"We are also pleased that the SBRI has identified Proventec as a developer of innovative technology. We look forward to expanding our portfolio of products to include hand hygiene, which is one of the key areas we need to target to prevent the spread of infection."- Ends -
For further information, please contact:
|David Chestnutt, Chief Executive||Tel: + 44 (0) 151 706 0626|
Seymour Pierce Limited
|Paul Davies, Corporate Finance||Tel: + 44 (0) 20 7107 8031|
|Henry Harrison-Topham / Stephanie Cuthbert||Tel: +44 (0) 20 7398 7718|
Notes to editors:
Proventec manages a complementary portfolio of integrated businesses that specialise in hygienic solutions and preventative coatings technologies. Headquartered in Liverpool, UK, the Company operates in global markets, pioneering developments within the healthcare, food manufacturing, hospitality industries, transportation, construction, and other sectors. Companies in Proventec's portfolio include:
|OspreyDeepClean||The world's leading provider of low pressure, chemical-free, specialist dry saturated steam cleaning technology.||34|
|Contico Manufacturing||Provider of general cleaning products and janitorial equipment and supplies.||45|
|Frank||Manufacturer and distributer of automated cleaning systems and products including portable high pressure washers, self-service vehicle wash stations and dry steamers.||22|
|CryoJet||Provider of a specialised, industrial cleaning service, utilising steam and proprietary dry-ice technology.||25|
|Magma Firestop||Develops a wide of range fire retardant coatings, for the treatment of building and thatching materials.||4|
|InnoShield Systems||Develops transparent coatings protecting against UV rays and corrosion.||1|
Proventec Healthcare provides innovative solutions for infection control and effective cleaning in the healthcare sector. The Company's specialist steam cleaning technology has been successfully proven in clinical trials with University College London Hospitals to rid all areas and combat the spread of micro-organisms, including 'superbugs' such as MRSA and Clostridium difficile. The Company has developed specialist, patented tooling, which has been designed to be used within hospitals on a daily basis and enable the user to clean difficult to reach areas including mattresses, bed frames and curtains without the use of antimicrobial chemicals that may contribute to microbial resistance.
The Company joined the AIM Market in June 2002 and was dual listed on Alternext in May 2008. For further information please visit www.proventecplc.comInformation réglementée
Communiqués au titre de l'obligation d'information permanente :
- Autres communiqués Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-15476-cp_proventec_en_300309.pdf © Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
|OSPREYFRANK||Euronext Paris||0.0100 (c)||0.00%||0|